Patents-Review.com
ClassID:

96361 ⎘

C07H7/033 - CPC Classification

Classification description:

Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond; Acyclic radicals Uronic acids

Recent Application in this class:
#1
20260132162
2026-05-14

KITS FOR IMPROVING THE FLUORESCENT SIGNAL OF DMB-LABELED SIALIC ACIDS

 #2
20240124509
2024-04-18

SEPARATION OF CHARGED OLIGOSACCHARIDES

 #3
20220298195
2022-09-22

Class of sucrose esters and a method for their preparation

 #4
20220242896
2022-08-04

METHODS AND KITS TO IMPROVE THE FLUORESCENT SIGNAL OF DMB-LABELED SIALIC ACIDS

 #5
20210047356
2021-02-18

Class of sucrose esters and a method for their preparation

 #6
20210017570
2021-01-21

DETECTION OF OLIGOSACCHARIDES

 #7
20200078477
2020-03-12

Imaging agents and methods of use

 #8
20200055888
2020-02-20

Method for preparing oligomeric mannuronic diacid

 #9
20200045962
2020-02-13

METHOD FOR PREPARING SURFACTANT COMPOSITIONS COMPRISING ALKYL LIDURONAMIDES D-GLUCURONAMIDES AND L-RHAMNOSIDES FROM ULVANS

 #10
20180207195
2018-07-26

Oxidized α-1,4-oligoglucuronic acid, and preparation method therefor and uses thereof

 #11
20180080059
2018-03-22

Detection of oligosaccharides

 #12
20170305829
2017-10-26

Oxidation of uronic acids to aldaric acids

 #13
20150307915
2015-10-29

Detection of oligosaccharides

 #14
20150065749
2015-03-05

Catalytic oxidation of uronic acids to aldaric acids

 #15
20150005485
2015-01-01

Synthetic heparin pentasaccharides

 #16
20120220759
2012-08-30

Synthetic heparin disaccharides

 #17
20120208993
2012-08-16

Synthetic heparin trisaccharides

 #18
20120184497
2012-07-19

DALBAVANCIN COMPOSITIONS FOR TREATMENT OF BACTERIAL INFECTIONS

 #19
20110224169
2011-09-15

Hyaluronic acid oligosaccharide fractions and drugs containing the same

 #20
20100184013
2010-07-22

Detection of oligosaccharides

 #21
20100152435
2010-06-17

COMPOSITIONS AND PROCESSES FOR THE SELECTIVE CATALYTIC OXIDATION OF ALCOHOLS

 #22
20100113390
2010-05-06

OLIGOSACCHARIDES DERIVED FROM FUCOIDAN

 #23
20100004184
2010-01-07

Anti-hypercholesterolemic compounds

 #24
20090298749
2009-12-03

Dalbavancin compositions for treatment of bacterial infections

 #25
20090291914
2009-11-26

HYALURONIC ACID OLIGOSACCHARIDE FRACTIONS AND DRUGS CONTAINING THE SAME

 #26
20090187013
2009-07-23

Synthetic heparin monosaccharides

 #27
20080182983
2008-07-31

HYALURONIC ACID OLIGOSACCHARIDE FRACTIONS AND DRUGS CONTAINING THE SAME

 #28
20080119556
2008-05-22

Geranyl compounds

 #29
20080113939
2008-05-15

Mevalonic acid derivatives

 #30
20080041366
2008-02-21

Method of obtaining an organic salt or acid from an aqueous sugar stream

 #31
20070134646
2007-06-14

Hyaluronic acid oligosaccharide fractions and drugs containing the same

 #32
20070099826
2007-05-03

Treatment of diseases associated with the egr-1 enhancer element

 #33
20060183715
2006-08-17

Sulfated fucoglucuronomannan

 #34
20060142244
2006-06-29

Geranyl compounds

 #35
20060135439
2006-06-22

Therapeutic agent for nerve damage

 #36
20060074014
2006-04-06

Dalbavancin compositions for treatment of bacterial infections

 #37
20060003945
2006-01-05

Indolylalkylamine metabolites as 5-hydroxytryptamine-6 ligands

 #38
20050202064
2005-09-15

Product of heat treatment of uronic acid, food, drink or drug including the product

 #39
20050130908
2005-06-16

Glycuronamides, glycosides and orthoester glycosides of fluoxetine, analogs and uses thereof

 #40
20050119474
2005-06-02

Geranyl compounds

 #41
20050113313
2005-05-26

Method of obtaining D-glucuronic acid

 #42
20050107310
2005-05-19

Carboxylic acid glycuronides, glycosamides and glycosides of quinolones, penicillins, analogs, and uses thereof

 #43
20050090662
2005-04-28

Method of making free acids from polysaccharide salts

 #44
20050090661
2005-04-28

Hyaluronic acid oligosaccharide fractions and drugs containing the same

 #45
20050090456
2005-04-28

Sulfated fucoglucuronomannan

 #46
20050080042
2005-04-14

Synthetic heparin pentasaccharides

 #47
20050009759
2005-01-13

Derivatives of etoposide and analogs, and pharmaceutical compositions containing them